By Julia Ivanova, MA; Michael Saks, PhD; George Karway, MS; Anita Murcko, MD; Candy Espino, MBA; Chase Millea, JD; Melissa Soliz, JD; and Adela Grando
The objective of the study was to learn how substance use disorder (SUD) treatment organizations view and respond to changes in confidentiality and disclosure law following adoption of CARES Act Sec. 3221 and prior to promulgation of revised implementing regulations.